The product, Extracellular Vesicle Isolate Product, was injected into the patients to assist with OA of the knee, shoulder, elbow, ankle and wrist.
The stem cell treatment demonstrated improvements ranging from 40 percent to 98 percent, with the average improvement over 70 percent.
Dr. Pettine coinvented the Prestige cervical artificial disc and the Maverick artificial disc. He is the principal investigator of 18 FDA studies evaluating non-fusion implants, biologics and stem cells.
More articles on orthopedics:
9 things to know about Rothman Orthopaedic Institute
Mass hires of orthopedic surgeons at 3 hospitals, health systems
HSS opens 1st Florida hospital, 2nd new facility in 1 week
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.